№ lp_1_2_12681
File format: docx
Character count: 43775
File size: 458 KB
This guideline provides evidence-based strategies for managing persistent pain in patients with chronic kidney disease, emphasizing both pharmacological and non-pharmacological approaches for healthcare providers.
Year:
2023
Region / city:
Canberra
Subject:
Chronic Kidney Disease, Pain Management
Document Type:
Guideline
Organization / Institution:
Canberra Health Services
Author:
Unknown
Target Audience:
CHS medical staff
Effective Period:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2016
Region / city:
Rome
Subject:
Persistent Organic Pollutants, Hexachlorobutadiene
Document type:
Technical note
Organ / institution:
United Nations Environment Programme (UNEP)
Author:
UNEP Secretariat
Target audience:
Parties to the Stockholm Convention, environmental policy makers, industrial stakeholders
Period of validity:
2016-2017
Approval date:
5 October 2016
Modification date:
N/A
Year:
2012
Region / City:
Global
Topic:
Recycling, Environmental Protection, Chemicals
Document Type:
Technical Guidance
Organization:
Stockholm Convention Secretariat, UNEP, UNIDO, UNITAR, UN
Author:
Stockholm Convention Secretariat
Target Audience:
Environmental agencies, recycling industries, waste management professionals
Period of Validity:
Ongoing
Approval Date:
July 2012
Amendment Date:
Not specified
Year:
2015-2018
Region / city:
Sub-Saharan Africa
Thematic Area:
Transparent and Accountable Governance
Document Type:
Project Proposal
Organization / Institution:
United Nations Development Programme (UNDP), Ministry of Health (Ghana)
Author:
UNDP, WHO, Health Care Without Harm
Target Audience:
Ministries, Departments, Local Governments, Civil Society Organizations (CSOs), Healthcare professionals, Policy makers
Implementation Period:
2015 – 2018
Date of Approval:
20th November, 2014
Amendment Date:
N/A
Year:
2027
Jurisdiction:
State of South Carolina
Subject:
Criminal domestic violence
Document type:
Legislative bill
Legislative body:
General Assembly of the State of South Carolina
Responsible agency:
State Law Enforcement Division
Registry name:
Persistent Criminal Domestic Violence Offender Registry
Effective date:
Upon approval by the Governor
Applicability date:
January 1, 2027
Registration fee:
One hundred dollars
Public access:
Online public inquiry
Retention periods:
Two, five, or ten years based on number of prior convictions
Year:
2025
Region / City:
Augusta, GA, USA
Topic:
Cyber Training, Artificial Intelligence, Help Desk Solutions
Document Type:
Special Notice
Agency:
Department of Defense
Author:
Army Contracting Command
Target Audience:
U.S. Citizens
Effective Period:
August 18, 2025 - September 26, 2025
Approval Date:
August 18, 2025
Amendment Date:
N/A
Classification:
D -- Information Technology services
NAICS Code:
541 -- Professional, Scientific, and Technical Services/541330 -- Engineering Services
Place of Performance:
Augusta, GA, USA
Year:
2021
Language:
English
Medical field:
Pain management
Therapeutic class:
Gabapentinoids
Medications covered:
Gabapentin; Pregabalin
Indications discussed:
Neuropathic pain
Patient population:
Adults with persistent pain
Document type:
Clinical guidance
Related guidance:
Analgesic Tapering Guidelines for adult patients with persistent pain taking strong opioids and/or gabapentinoids
Regulatory references:
NICE; MHRA
Dosage information:
Included
Tapering schedules:
Included
Risk considerations:
Adverse effects; withdrawal effects; opioid co-prescribing risks
Geographic context:
United Kingdom
Evidence sources:
Cochrane Reviews; NICE guidance; Summary of Product Characteristics
Year:
2016
Region / city:
Western Australia
Topic:
Persistent pain management
Document type:
Policy framework
Organization / institution:
Western Australian Health
Author:
Musculoskeletal Health Network (MSK HN)
Target audience:
Healthcare providers, policymakers, community
Period of action:
2016-2021
Date of approval:
February 2014
Date of amendments:
Not specified
Year:
2008
Region / City:
Australia
Subject:
Environmental monitoring, sewage sludge, persistent organic pollutants (POPs)
Document type:
PhD Thesis
Author:
Clarke, B.O.
Target audience:
Environmental scientists, researchers in applied sciences
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A
Description:
The document discusses the identification, monitoring, and risks associated with persistent organic pollutants (POPs) in Australian sewage sludge.
Year:
2026
Region / City:
Not specified
Topic:
Biomedical research, antifungal coatings
Document Type:
Research article
Institution / Organization:
Not specified
Author:
Not specified
Target Audience:
Researchers, biomedical engineers, healthcare professionals
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2015
Region / City:
New Zealand
Topic:
Digital Scholarship
Document Type:
Survey
Institution:
Alexander Turnbull Library
Author:
Cameron M. Pierson
Target Audience:
Researchers, academics, post-graduate students
Period of Action:
Until 25/8/2015
Approval Date:
Not specified
Date of Changes:
Not specified
Confidentiality:
Approved by Alexander Turnbull Library
Contact:
[email protected]
Year:
2023
Region / city:
Cambridge, Milan, Catanzaro, Rome, Rochester
Topic:
Neuroticism, neuroimaging, vestibular disorders, fMRI, persistent postural-perceptual dizziness (PPPD)
Document Type:
Research Article
Institution:
University of Cambridge, National Research Council, Mayo Clinic, Saint Camillus International University of Health Sciences
Authors:
Luca Passamonti, Roberta Riccelli, Francesco Lacquaniti, Jeffrey P Staab, Iole Indovina
Target Audience:
Researchers, medical professionals, clinicians, neuroscientists
Period of Activity:
Ongoing
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2025
Region / Area:
Mungo Division, Littoral Region, Cameroon
Subdivisions:
Bonalea; Dibombari; Mbanga
Subject:
Non-timber forest products (NTFPs); value chain analysis; sustainability; rural livelihoods
Focus Species:
Gnetum africanum (Eru / Okok)
Type of Document:
Academic research article
Methodology:
Mixed-methods; structured questionnaires; focus group discussions; key informant interviews
Sample Size:
278 value chain actors
Comparative Baseline Year:
2009
Time Span Covered:
2009–2025
Key Themes:
Economic inequality; gender dynamics; environmental sustainability; domestication; trade formalization
Geographical Scope of Trade:
Local, national, and cross-border (including Nigeria and Gabon)
Keywords:
Gnetum africanum; NTFPs; value chain; sustainability; Cameroon
Year:
2019
Region / City:
Rome
Topic:
Persistent Organic Pollutants Review Committee
Document Type:
Official Note
Organization:
United Nations Environment Programme (UNEP)
Author:
Secretariat
Target Audience:
Parties to the Stockholm Convention on Persistent Organic Pollutants, Members of the Persistent Organic Pollutants Review Committee
Effective Period:
1 October 2019 – 4 May 2020
Date of Approval:
23 July 2019
Date of Changes:
None
Context:
Official note summarizing the rotation of membership of the Persistent Organic Pollutants Review Committee under the Stockholm Convention, detailing appointments, terms, and forthcoming rotations.
Year:
2022
Region / City:
Global
Topic:
EMDR, PTSD, Pain Management
Document Type:
Webinar
Organization:
N/A
Author:
David Pyke
Target Audience:
Healthcare professionals, therapists, patients with chronic pain
Period of Action:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2007
Region / City:
England
Subject:
Education
Document Type:
Warning Letter
Organization:
Local Authority
Author:
Head Teacher
Target Audience:
Parents
Effective Period:
15 school days from the date of this letter
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2026
Region / city:
European Union
Topic:
Personalized Medicine for Cardiovascular, Metabolic, and Kidney Diseases
Document type:
Pre-proposal application form
Organization / Institution:
European Union Funding Agencies
Author:
Not specified
Target audience:
Research institutions, academic institutions, and industry partners
Duration:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Contextual description:
A pre-proposal application form for the CARMEN2026 joint transnational call for proposals aimed at personalized medicine for cardiovascular, metabolic, and kidney diseases.
Year:
2023
Region / city:
Australia
Topic:
Chronic hyperkalaemia, kidney disease, sodium zirconium cyclosilicate
Document Type:
Submission to PBAC
Agency / organization:
AstraZeneca Pty Ltd
Author:
Not specified
Target audience:
Medical practitioners, healthcare professionals
Period of validity:
Ongoing, based on PBAC recommendation and PBS listing
Approval date:
1 September 2023
Date of amendments:
Not specified
Year:
2015
Country:
New Zealand
City:
Wellington
Subject:
Chronic kidney disease
Document type:
National consensus statement
Issuing body:
Ministry of Health
Authors:
CKD Core Work Group
Target audience:
Clinicians and managers in funder and provider organisations
Healthcare setting:
Primary care
Publication date:
March 2015
ISBN:
978-0-478-44476-6
License:
Creative Commons Attribution 4.0 International
Focus population:
Adults with chronic kidney disease
Clinical scope:
Identification, classification, and management of CKD
Period covered:
Contemporary clinical practice as of 2015
Canberra Health Services Guideline Apixaban and Rivaroxaban Use in Adults with Severe Kidney Disease
Year:
2021
Region / City:
Canberra, Australia
Topic:
Pharmacology / Kidney Disease
Document Type:
Clinical Guideline
Institution:
Canberra Health Services
Author:
Not specified
Target Audience:
Medical staff and pharmacists
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified